Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Xianli Tong"'
Autor:
Bangzhu Mo, Yuanxin Ye, Maowen Yu, Xianli Tong, Hongmei Cao, Chunmei Du, Jiangrong Luo, Chunbao Xie
Publikováno v:
Cancer Medicine, Vol 13, Iss 16, Pp n/a-n/a (2024)
Abstract Background Human papillomavirus (HPV) screening and vaccination exert efficacy in controlling the progression of cervical cancer. Thus, examinations into HPV prevalence, age‐stratified specificity, genotype distribution, and their correlat
Externí odkaz:
https://doaj.org/article/dfe5da4a27ac4b94a95d3593c281c79d
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
BackgroundIn recent years, microRNA-1-3p (miR-1-3p) has been linked to the progression of multiple cancers, whereas little is known about its role in hepatocellular carcinoma (HCC). Herein, we investigated the function of miR-1-3p in HCC, and its reg
Externí odkaz:
https://doaj.org/article/6e8ea5ca34704a8fa052a1bf82b2228f
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 111, Iss , Pp 1353-1358 (2019)
Better understanding of the molecular mechanism involved in hepatocellular carcinoma (HCC) progression is essential for the development of therapeutic strategies to overcome chemoresistance in HCC patients. In this work, we show that 6-phosphoglucona
Externí odkaz:
https://doaj.org/article/76c7eb0aed9547f6a5c83419eb7da6cb
Autor:
Jing Yu, Dongqing Li, Dansheng Lei, Feng Yuan, Feng Pei, Huifeng Zhang, Anming Yu, Kun Wang, Hu Chen, Liang Chen, Xianglei Wu, Xianli Tong, Yefu Wang
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0165390 (2016)
D-dimer level in cancer patients is associated with risk of venous thromboembolism and deep venous thrombosis. Most cancer patients have "abnormal" D-dimer levels based on the current normal reference range. To investigate tumor-specific D-dimer refe
Externí odkaz:
https://doaj.org/article/b21fdb5d400e4b8197b43f43ba550aae
Publikováno v:
Biochemical and Biophysical Research Communications. 523:147-152
Hepatocellular carcinoma which is featured with the extensive vascularization is the third most frequent cause of cancer-related deaths with limited therapeutic options, particularly for advanced disease. Cobimetinib, a MEK inhibitor, has been approv
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology
BackgroundIn recent years, microRNA-1-3p (miR-1-3p) has been linked to the progression of multiple cancers, whereas little is known about its role in hepatocellular carcinoma (HCC). Herein, we investigated the function of miR-1-3p in HCC, and its reg
Autor:
Jianping Bi, Wenhua Liang, Xianli Tong, Guang Han, Desheng Hu, Ran Zhong, Yongping Lin, Vivek Verma, Jianxing He, Yanping Li, Hongwei Shi, Guowu Jiang, Jianfu Li
Publikováno v:
The Journal of Infection
Journal of Infection
Journal of Infection
• We retrospectively studied the prevalence and clinical characterization of cancer patients with asymptomatic SARS-CoV-2 infection history in the only cancer hospital in Wuhan. • Serosurvey of SARS-CoV-2 among hospital visitors from two hospital
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 111, Iss, Pp 1353-1358 (2019)
Better understanding of the molecular mechanism involved in hepatocellular carcinoma (HCC) progression is essential for the development of therapeutic strategies to overcome chemoresistance in HCC patients. In this work, we show that 6-phosphoglucona
Autor:
Dansheng Lei, Yefu Wang, Jing Yu, Kun Wang, Dongqing Li, Liang Chen, Feng Yuan, Hu Chen, Xianli Tong, Huifeng Zhang, Xianglei Wu, Feng Pei, Anming Yu
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0165390 (2016)
PLoS ONE
PLoS ONE
D-dimer level in cancer patients is associated with risk of venous thromboembolism and deep venous thrombosis. Most cancer patients have "abnormal" D-dimer levels based on the current normal reference range. To investigate tumor-specific D-dimer refe